Edwin Rock

Insider Reports History

Location
Rockville, MD
Signature
/s/ Brian F. Leaf, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Edwin Rock:

Company Role Class Num Shares Value Price $ Report Date Ownership
GLYCOMIMETICS INC Chief Medical Officer Common Stock 680,403 $181,736 $0.2671 21 Jun 2024 Direct
GLYCOMIMETICS INC Chief Medical Officer Employee Stock Option (right to buy) 250,000 12 Jan 2024 Direct

Insider Reports Filed by Edwin Rock

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GLYC GLYCOMIMETICS INC 20 Jun 2024 2 +$78,824 4 Chief Medical Officer 24 Jun 2024, 16:29
GLYC GLYCOMIMETICS INC 12 Jan 2024 1 $0 4 Chief Medical Officer 17 Jan 2024, 16:05
GLYC GLYCOMIMETICS INC 21 Sep 2023 2 +$90,256 4 Chief Medical Officer 25 Sep 2023, 17:21
GLYC GLYCOMIMETICS INC 19 Jan 2023 1 $0 4 Chief Medical Officer 20 Jan 2023, 15:02
GLYC GLYCOMIMETICS INC 22 Dec 2022 1 +$247,500 4 Chief Medical Officer 27 Dec 2022, 17:41
GLYC GLYCOMIMETICS INC 14 Nov 2022 2 +$309,000 4 Chief Medical Officer 16 Nov 2022, 15:26
GLYC GLYCOMIMETICS INC 02 Sep 2022 1 $0 4 Chief Medical Officer 07 Sep 2022, 16:10
GLYC GLYCOMIMETICS INC 02 Sep 2022 0 $0 3 Chief Medical Officer 07 Sep 2022, 16:08